Question follow-through · 12009

Mental Health Services

To ask the Secretary of State for Health and Social Care, if he will take steps to (a) increase (i) capacity and (ii) coordination among mental health services to ensure people receive treatment close to home, (b) provide free prescriptions to people with

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
30 Oct 2024
Target answer date
4 Nov 2024
Answer
14 Nov 2024 · 15 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 30 Oct 2024

    Question tabled

    To ask the Secretary of State for Health and Social Care, if he will take steps to (a) increase (i) capacity and (ii) coordination among mental health services to ensure people receive treatment close to home, (b) provide free prescriptions to people with

  2. 4 Nov 2024

    Target answer date

    Date supplied by the official written-questions record.

  3. 14 Nov 2024

    Answer published

    As part of our mission to build a National Health Service fit for the future, we are committed to shifting care out of hospitals and into the community, close to people’s homes. NHS England is currently piloting neighbourhood based, open access community ...

Open official record

Official data retrieved 27 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Members: Correspondence

4 Nov 2024 · To ask the Secretary of State for Health and Social Care, when he plans to respond to the letter of 22 July 2024 from the hon. member for Henley and Thame about step down beds at Chiltern Court, Henley on Thames.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Dementia: Care Workers

18 Nov 2024 · To ask the Secretary of State for Health and Social Care, what progress he has made on dementia care in his plans for social care workforce reform; and if he will make an assessment of the potential merits of making dementia training mandatory for adult s

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Respiratory Syncytial Virus: Vaccination

19 Nov 2024 · To ask the Secretary of State for Health and Social Care, when he plans to publish real world evidence on the effectiveness of the respiratory syncytial virus vaccine in the 75-80 cohort; how much such evidence has been collected; and whether such evidenc

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Respiratory Syncytial Virus: Vaccination

19 Nov 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his Department’s policies of the recommendation from the French health authority that the RSV vaccine should be provided to (a) 75-80 a

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Gluten-free Foods: Prescriptions

19 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether he plans to take steps to help support people with Coeliac disease with the cost of food; and if he will make an assessment of the potential merits of widening access to gluten free product

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Spinal Muscular Atrophy: Babies

19 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of testing newborn babies for spinal muscular atrophy.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Physician Associates: Training

21 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the adequacy of (a) patient knowledge of the training physicians associates receive and (b) information available in general practice for patients on physician

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Physician Associates: Finance and Incentives

21 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will review the (a) incentives and (b) funding for physician associates.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Take-up

21 Nov 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the uptake of (a) digital innovation and (b) patient data systems within the NHS.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Hospitals: Construction

4 Dec 2024 · To ask the Secretary of State for Health and Social Care, with reference to the New Hospital Programme review, when the (a) options and (b) recommendations for the Royal Berkshire Hospital, Reading will be published; and when he plans to announce which ho

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Givinostat

10 Dec 2024 · To ask the Secretary of State for Health and Social Care, how many patients were in receipt of Givinostat through the Early Access Programme on 10 December 2024; and if he will make an assessment of the potential barriers to accessing the Early Access Pro

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Medical Treatments

10 Dec 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking to support NHS Trusts to speed up access to innovative therapies before MHRA approval through Early Access Programmes.